ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -18.8% | 63,500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $16,000 | -11.1% | 63,500 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $18,000 | -50.0% | 63,500 | 0.0% | 0.01% | -62.5% |
| Q4 2021 | $36,000 | -44.6% | 63,500 | 0.0% | 0.02% | -48.4% |
| Q3 2021 | $65,000 | -31.6% | 63,500 | -7.3% | 0.03% | -29.5% |
| Q2 2021 | $95,000 | -12.0% | 68,500 | +7.9% | 0.04% | -20.0% |
| Q1 2021 | $108,000 | +36.7% | 63,500 | 0.0% | 0.06% | +31.0% |
| Q4 2020 | $79,000 | -12.2% | 63,500 | 0.0% | 0.04% | -30.0% |
| Q3 2020 | $90,000 | +21.6% | 63,500 | +3.3% | 0.06% | +33.3% |
| Q2 2020 | $74,000 | +1.4% | 61,500 | 0.0% | 0.04% | -13.5% |
| Q1 2020 | $73,000 | -43.8% | 61,500 | 0.0% | 0.05% | -3.7% |
| Q4 2019 | $130,000 | +20.4% | 61,500 | +99.0% | 0.05% | +10.2% |
| Q1 2019 | $108,000 | – | 30,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |